nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethotoin—SCN11A—head—thyroid cancer	0.0707	0.104	CbGeAlD
Ethotoin—SCN7A—thyroid gland—thyroid cancer	0.0677	0.0996	CbGeAlD
Ethotoin—SCN7A—head—thyroid cancer	0.0601	0.0884	CbGeAlD
Ethotoin—SCN8A—head—thyroid cancer	0.0536	0.0788	CbGeAlD
Ethotoin—SCN4A—thyroid gland—thyroid cancer	0.0473	0.0696	CbGeAlD
Ethotoin—SCN7A—lymph node—thyroid cancer	0.0421	0.0619	CbGeAlD
Ethotoin—SCN4A—head—thyroid cancer	0.042	0.0618	CbGeAlD
Ethotoin—SCN1A—head—thyroid cancer	0.0405	0.0596	CbGeAlD
Ethotoin—SCN2A—head—thyroid cancer	0.0372	0.0547	CbGeAlD
Ethotoin—SCN3A—thyroid gland—thyroid cancer	0.0368	0.0542	CbGeAlD
Ethotoin—SCN10A—head—thyroid cancer	0.0358	0.0527	CbGeAlD
Ethotoin—SCN9A—lymph node—thyroid cancer	0.033	0.0485	CbGeAlD
Ethotoin—SCN3A—head—thyroid cancer	0.0327	0.048	CbGeAlD
Ethotoin—SCN5A—head—thyroid cancer	0.0326	0.0479	CbGeAlD
Ethotoin—SCN10A—lymph node—thyroid cancer	0.0251	0.0369	CbGeAlD
Ethotoin—SCN3A—lymph node—thyroid cancer	0.0229	0.0336	CbGeAlD
Ethotoin—Stevens-Johnson syndrome—Vandetanib—thyroid cancer	0.0169	0.0528	CcSEcCtD
Ethotoin—Erythema multiforme—Vandetanib—thyroid cancer	0.0145	0.0452	CcSEcCtD
Ethotoin—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.0114	0.0356	CcSEcCtD
Ethotoin—Chest pain—Vandetanib—thyroid cancer	0.0114	0.0355	CcSEcCtD
Ethotoin—Nystagmus—Epirubicin—thyroid cancer	0.0106	0.0333	CcSEcCtD
Ethotoin—Nystagmus—Doxorubicin—thyroid cancer	0.00985	0.0308	CcSEcCtD
Ethotoin—Insomnia—Vandetanib—thyroid cancer	0.00984	0.0307	CcSEcCtD
Ethotoin—Erythema multiforme—Sorafenib—thyroid cancer	0.00977	0.0305	CcSEcCtD
Ethotoin—Fatigue—Vandetanib—thyroid cancer	0.00938	0.0293	CcSEcCtD
Ethotoin—Body temperature increased—Vandetanib—thyroid cancer	0.0086	0.0269	CcSEcCtD
Ethotoin—Asthenia—Vandetanib—thyroid cancer	0.00781	0.0244	CcSEcCtD
Ethotoin—Diarrhoea—Vandetanib—thyroid cancer	0.00745	0.0233	CcSEcCtD
Ethotoin—Dizziness—Vandetanib—thyroid cancer	0.0072	0.0225	CcSEcCtD
Ethotoin—Vomiting—Vandetanib—thyroid cancer	0.00692	0.0216	CcSEcCtD
Ethotoin—Rash—Vandetanib—thyroid cancer	0.00686	0.0214	CcSEcCtD
Ethotoin—Dermatitis—Vandetanib—thyroid cancer	0.00685	0.0214	CcSEcCtD
Ethotoin—Headache—Vandetanib—thyroid cancer	0.00682	0.0213	CcSEcCtD
Ethotoin—Lymphadenopathy—Epirubicin—thyroid cancer	0.00647	0.0202	CcSEcCtD
Ethotoin—Nausea—Vandetanib—thyroid cancer	0.00646	0.0202	CcSEcCtD
Ethotoin—Fatigue—Sorafenib—thyroid cancer	0.00633	0.0198	CcSEcCtD
Ethotoin—Lymphadenopathy—Doxorubicin—thyroid cancer	0.00599	0.0187	CcSEcCtD
Ethotoin—Body temperature increased—Sorafenib—thyroid cancer	0.0058	0.0181	CcSEcCtD
Ethotoin—Diplopia—Epirubicin—thyroid cancer	0.00552	0.0172	CcSEcCtD
Ethotoin—Asthenia—Sorafenib—thyroid cancer	0.00527	0.0165	CcSEcCtD
Ethotoin—Ataxia—Epirubicin—thyroid cancer	0.00519	0.0162	CcSEcCtD
Ethotoin—Diplopia—Doxorubicin—thyroid cancer	0.00511	0.016	CcSEcCtD
Ethotoin—Diarrhoea—Sorafenib—thyroid cancer	0.00502	0.0157	CcSEcCtD
Ethotoin—Dizziness—Sorafenib—thyroid cancer	0.00485	0.0152	CcSEcCtD
Ethotoin—Ataxia—Doxorubicin—thyroid cancer	0.0048	0.015	CcSEcCtD
Ethotoin—Vomiting—Sorafenib—thyroid cancer	0.00467	0.0146	CcSEcCtD
Ethotoin—Rash—Sorafenib—thyroid cancer	0.00463	0.0145	CcSEcCtD
Ethotoin—Dermatitis—Sorafenib—thyroid cancer	0.00462	0.0144	CcSEcCtD
Ethotoin—Headache—Sorafenib—thyroid cancer	0.0046	0.0144	CcSEcCtD
Ethotoin—Nausea—Sorafenib—thyroid cancer	0.00436	0.0136	CcSEcCtD
Ethotoin—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.00422	0.0132	CcSEcCtD
Ethotoin—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.0039	0.0122	CcSEcCtD
Ethotoin—Hypoaesthesia—Epirubicin—thyroid cancer	0.0038	0.0119	CcSEcCtD
Ethotoin—Erythema multiforme—Epirubicin—thyroid cancer	0.00361	0.0113	CcSEcCtD
Ethotoin—Hypoaesthesia—Doxorubicin—thyroid cancer	0.00352	0.011	CcSEcCtD
Ethotoin—Erythema multiforme—Doxorubicin—thyroid cancer	0.00334	0.0104	CcSEcCtD
Ethotoin—Chest pain—Epirubicin—thyroid cancer	0.00283	0.00884	CcSEcCtD
Ethotoin—Chest pain—Doxorubicin—thyroid cancer	0.00262	0.00818	CcSEcCtD
Ethotoin—Insomnia—Epirubicin—thyroid cancer	0.00245	0.00766	CcSEcCtD
Ethotoin—Fatigue—Epirubicin—thyroid cancer	0.00234	0.00731	CcSEcCtD
Ethotoin—Insomnia—Doxorubicin—thyroid cancer	0.00227	0.00709	CcSEcCtD
Ethotoin—Fatigue—Doxorubicin—thyroid cancer	0.00216	0.00676	CcSEcCtD
Ethotoin—Body temperature increased—Epirubicin—thyroid cancer	0.00214	0.0067	CcSEcCtD
Ethotoin—Body temperature increased—Doxorubicin—thyroid cancer	0.00198	0.0062	CcSEcCtD
Ethotoin—Asthenia—Epirubicin—thyroid cancer	0.00195	0.00608	CcSEcCtD
Ethotoin—Diarrhoea—Epirubicin—thyroid cancer	0.00186	0.0058	CcSEcCtD
Ethotoin—Asthenia—Doxorubicin—thyroid cancer	0.0018	0.00563	CcSEcCtD
Ethotoin—Dizziness—Epirubicin—thyroid cancer	0.00179	0.0056	CcSEcCtD
Ethotoin—Vomiting—Epirubicin—thyroid cancer	0.00172	0.00539	CcSEcCtD
Ethotoin—Diarrhoea—Doxorubicin—thyroid cancer	0.00172	0.00537	CcSEcCtD
Ethotoin—Rash—Epirubicin—thyroid cancer	0.00171	0.00534	CcSEcCtD
Ethotoin—Dermatitis—Epirubicin—thyroid cancer	0.00171	0.00534	CcSEcCtD
Ethotoin—Headache—Epirubicin—thyroid cancer	0.0017	0.00531	CcSEcCtD
Ethotoin—Dizziness—Doxorubicin—thyroid cancer	0.00166	0.00519	CcSEcCtD
Ethotoin—Nausea—Epirubicin—thyroid cancer	0.00161	0.00503	CcSEcCtD
Ethotoin—Vomiting—Doxorubicin—thyroid cancer	0.0016	0.00499	CcSEcCtD
Ethotoin—Rash—Doxorubicin—thyroid cancer	0.00158	0.00494	CcSEcCtD
Ethotoin—Dermatitis—Doxorubicin—thyroid cancer	0.00158	0.00494	CcSEcCtD
Ethotoin—Headache—Doxorubicin—thyroid cancer	0.00157	0.00491	CcSEcCtD
Ethotoin—Nausea—Doxorubicin—thyroid cancer	0.00149	0.00466	CcSEcCtD
